311 related articles for article (PubMed ID: 21441817)
1. Rituximab in the treatment of bullous systemic lupus erythematosus.
Alsanafi S; Kovarik C; Mermelstein AL; Werth VP
J Clin Rheumatol; 2011 Apr; 17(3):142-4. PubMed ID: 21441817
[TBL] [Abstract][Full Text] [Related]
2. Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage.
Pottier V; Pierrot M; Subra JF; Mercat A; Kouatchet A; Parrot A; Augusto JF
Lupus; 2011 May; 20(6):656-9. PubMed ID: 21335399
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus.
Catapano F; Chaudhry AN; Jones RB; Smith KG; Jayne DW
Nephrol Dial Transplant; 2010 Nov; 25(11):3586-92. PubMed ID: 20466686
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
Uthman I; Taher A; Abbas O; Menassa J; Ghosn S
Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821
[No Abstract] [Full Text] [Related]
5. Rituximab and its use in autoimmune bullous disorders.
Daniel BS; Murrell DF; Joly P
Dermatol Clin; 2011 Oct; 29(4):571-5. PubMed ID: 21925000
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of recurrent pancreatitis secondary to systemic lupus erythematosus with B-cell depletion therapy.
Al-Musawi ZS; Nabar UJ
Arch Iran Med; 2011 Jan; 14(1):66-70. PubMed ID: 21194267
[TBL] [Abstract][Full Text] [Related]
7. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.
Garcia-Carrasco M; Mendoza-Pinto C; Sandoval-Cruz M; Soto-Vega E; Beltran-Castillo A; Jimenez-Hernandez M; Graillet D; Gonzalez L; Rojas-Rodriguez J; Pineda-Almazana A; Zamudio-Huerta L; Lopez-Colombo A
Lupus; 2010 Feb; 19(2):213-9. PubMed ID: 19965944
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
Goldblatt F; Isenberg DA
Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
[TBL] [Abstract][Full Text] [Related]
10. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
Looney RJ
Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
[TBL] [Abstract][Full Text] [Related]
11. Single dose of rituximab for pediatric-onset refractory systemic lupus erythematosus.
Ikeda F; Watanabe S; Aizawa-Yashiro T; Tsuruga K; Ito E; Tanaka H
Lupus; 2013 Dec; 22(14):1541-3. PubMed ID: 23966305
[No Abstract] [Full Text] [Related]
12. Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus.
Bakshi J; Hassan S; D'Cruz D; Chan A
Lupus; 2013 Dec; 22(14):1544-6. PubMed ID: 24014570
[No Abstract] [Full Text] [Related]
13. Remission of incapacitating acute cutaneous lupus erythematosus in a patient with systemic lupus erythematosus by B cell-depletive therapy.
Kok MR; Vos K; Bos JD; Tak PP
J Clin Rheumatol; 2010 Oct; 16(7):345. PubMed ID: 20859218
[No Abstract] [Full Text] [Related]
14. Rituximab - shadow, illusion or light?
van Vollenhoven RF
Autoimmun Rev; 2012 Jun; 11(8):563-7. PubMed ID: 22036829
[TBL] [Abstract][Full Text] [Related]
15. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease.
Li Y; Foshee JB; Sontheimer RD
J Am Acad Dermatol; 2011 Apr; 64(4):773-8. PubMed ID: 20494477
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab.
Iwata S; Saito K; Tokunaga M; Yamaoka K; Nawata M; Yukawa S; Hanami K; Fukuyo S; Miyagawa I; Kubo S; Tanaka Y
J Rheumatol; 2011 Apr; 38(4):633-41. PubMed ID: 21159836
[TBL] [Abstract][Full Text] [Related]
17. Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.
Lim SW; Gillis D; Smith W; Hissaria P; Greville H; Peh CA
Intern Med J; 2006 Apr; 36(4):260-2. PubMed ID: 16640745
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy.
Tsai MJ; Chou CW; Lin FC; Chang SC
Lupus; 2012 Jul; 21(8):914-8. PubMed ID: 22287506
[TBL] [Abstract][Full Text] [Related]
19. Anti B cell therapy (rituximab) in the treatment of autoimmune diseases.
Kazkaz H; Isenberg D
Curr Opin Pharmacol; 2004 Aug; 4(4):398-402. PubMed ID: 15251135
[TBL] [Abstract][Full Text] [Related]
20. [Rationale and clinical evidence for the use of rituximab in glomerular diseases].
Mani LY; Vogt B; Burnier M; Golshayan D
Rev Med Suisse; 2011 Apr; 7(290):819-24. PubMed ID: 21595313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
